WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY) Sees Large Growth in Short Interest

WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY) was the target of a large growth in short interest in June. As of June 30th, there was short interest totaling 116,931 shares, a growth of 79.6% from the June 15th total of 65,100 shares. Based on an average trading volume of 145,649 shares, the short-interest ratio is currently 0.8 days. Approximately 0.0% of the company’s stock are short sold.

WuXi Biologics (Cayman) Stock Performance

Shares of WuXi Biologics (Cayman) stock opened at $9.50 on Friday. The company has a fifty day simple moving average of $8.56 and a 200-day simple moving average of $9.02. WuXi Biologics has a 12-month low of $7.07 and a 12-month high of $11.21.

About WuXi Biologics (Cayman)

WuXi Biologics (Cayman) Inc, trading OTC as WXXWY, is a global contract research, development and manufacturing organization (CDMO) specializing in biologics. Founded as a spin-out from WuXi AppTec and incorporated in the Cayman Islands in 2017, the company offers end-to-end support across the biologics value chain. Its service portfolio encompasses discovery biology, analytical development, process chemistry and large-scale manufacturing for therapeutic proteins and antibodies.

The firm’s core offerings include the development of monoclonal antibodies, recombinant proteins and cell and gene therapy vectors.